Compounds > cabergoline
Page last updated: 2024-08-23

cabergoline and bim 23a760

cabergoline has been researched along with bim 23a760 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barbieri, F; Culler, MD; Dong, J; Dufour, H; Feelders, RA; Florio, T; Gunz, G; Hofland, LJ; Jaquet, P; Moreau, JP; Saveanu, A; Spaziante, R; Stalla, GK; Taylor, JE; Theodoropoulou, M; van Koetsveld, PM; Zona, G1
Barbieri, F; Culler, MD; Ferone, D; Florio, T; Gatti, M; Gatto, F; Giusti, M; Hofland, LJ; Minuto, F; Ravetti, JL; Saveanu, A; Schulz, S; Wurth, R; Zona, G1
Barlier, A; Couderc, B; Cuny, T; Defilles, C; Enjalbert, A; Figarella-Branger, D; Germanetti, AL; Graillon, T; Mohamed, A; Roche, C; Saveanu, A1
Culler, MD; de Herder, WW; Dogan-Oruc, F; Feelders, RA; Herrera-Martínez, AD; Hofland, LJ; Luque, RM; van den Dungen, R; van Koetsveld, PM1

Other Studies

4 other study(ies) available for cabergoline and bim 23a760

ArticleYear
Efficacy of a dopamine-somatostatin chimeric molecule, BIM-23A760, in the control of cell growth from primary cultures of human non-functioning pituitary adenomas: a multi-center study.
    Endocrine-related cancer, 2008, Volume: 15, Issue:2

    Topics: Adenoma; Adult; Aged; Antineoplastic Agents, Hormonal; Cabergoline; Cell Division; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Ergolines; Female; Fibroblasts; Humans; Male; Middle Aged; Octreotide; Pituitary Neoplasms; Receptors, Dopamine D2; Receptors, Somatostatin; RNA, Messenger; Somatostatin; Sulpiride; Thymidine; Tritium; Tumor Cells, Cultured

2008
Balance between somatostatin and D2 receptor expression drives TSH-secreting adenoma response to somatostatin analogues and dopastatins.
    Clinical endocrinology, 2012, Volume: 76, Issue:3

    Topics: Adenoma; Adult; Cabergoline; Cell Proliferation; Dopamine; Dopamine Agonists; Drug Synergism; Ergolines; Gene Expression; Humans; Immunohistochemistry; Male; Octreotide; Pituitary Neoplasms; Protein Isoforms; Receptors, Dopamine D2; Receptors, Somatostatin; Reverse Transcriptase Polymerase Chain Reaction; Somatostatin; Thyrotropin; Thyroxine; Treatment Outcome; Triiodothyronine; Tumor Cells, Cultured

2012
Somatostatin receptor sst2 gene transfer in human prolactinomas in vitro: impact on sensitivity to dopamine, somatostatin and dopastatin, in the control of prolactin secretion.
    Molecular and cellular endocrinology, 2012, May-15, Volume: 355, Issue:1

    Topics: Adenoviridae; Adolescent; Adult; Cabergoline; Dopamine; Dopamine Agonists; Ergolines; Female; Genetic Vectors; Humans; Male; Octreotide; Pituitary Neoplasms; Primary Cell Culture; Prolactin; Prolactinoma; Receptors, Dopamine D2; Receptors, Somatostatin; Somatostatin; Transfection

2012
Effects of novel somatostatin-dopamine chimeric drugs in 2D and 3D cell culture models of neuroendocrine tumors.
    Endocrine-related cancer, 2019, Volume: 26, Issue:6

    Topics: Antineoplastic Agents, Hormonal; Cabergoline; Cell Culture Techniques; Cell Proliferation; Chromogranin A; Dopamine; Dopamine Agonists; Humans; Neuroendocrine Tumors; Octreotide; Receptors, Dopamine; Receptors, Somatostatin; Serotonin; Somatostatin; Spheroids, Cellular; Tumor Cells, Cultured

2019